MENLO PARK, CA--(Marketwire - November 08, 2007) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today reported financial results for the third quarter ended September 30, 2007.
For the third quarter of 2007, Corcept reported a net loss of $3.4 million, or $0.09 per share, compared to a net loss of $6.4 million, or $0.28 per share, for the third quarter of 2006. For the first nine months of 2007, the company reported a net loss of $7.4 million, or $0.23 per share, compared to a net loss of $20.1 million, or $0.93 per share, for the same period in 2006.
